Association between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple Sclerosis: A meta-regression and meta-analysis
- PMID: 33348212
- DOI: 10.1016/j.msard.2020.102687
Association between IL7 Receptor Alpha (Il7ra) gene rs6897932 polymorphism and the risk of Multiple Sclerosis: A meta-regression and meta-analysis
Abstract
Background: In this systematic review and meta-analysis, we aimed to find a consistent conclusion for the association between the interleukin 7 receptor alpha (IL7RA) gene rs6897932 single nucleotide polymorphism (SNP) and multiple sclerosis (MS) risk.
Methods: Here, we performed a comprehensive systematic search in PubMed, Scopus, and Web of Science to find relevant studies published before November 2020 investigating the association between rs6897932 SNP and MS risk. In the pooled analysis, we determined the odds ratio (OR) and the corresponding 95% confidence interval (CI) for the association level between rs6897932 SNP and the risk of MS.
Results: In the current meta-analysis 33 case-control studies (30 articles) containing 19351 patients and 21005 healthy controls certify the inclusion criteria. According to the pooled analysis, a statistically significant association of IL7RA gene rs6897932 SNP with MS risk was found across recessive model (OR= 0.84, 95% CI= 0.77-0.92, P< 0.001, FEM), allelic model (OR= 0.91, 95% CI= 0.85-0.99, P= 0. 02, REM), TT vs. CC model (OR= 0.79, 95% CI= 0.67-0.93, P= 0.005, REM). Moreover, the subgroup analysis based on the ethnicity indicated a negative significant association in Europeans; dominant model (OR= 0.88, 95% CI= 0.78-1.01, P= 0.06, REM), recessive model (OR= 0.79, 95% CI= 0.71-0.88, P< 0.001, REM), allelic model (OR= 0.88, 95% CI= 0.81-0.96, P= 0.003, REM), TT vs. CC model (OR= 0.74, 95% CI= 0.61-0.88, P<0.001, REM) models. Nonetheless, no significant association was detected in Asians and Americans.
Conclusions: IL7RA gene rs6897932 SNP decreases MS susceptibility in overall population and Europeans.
Keywords: Interleukin 7 receptor alpha; Meta-analysis; Multiple sclerosis; Single nucleotide polymorphisms.
Copyright © 2020 Elsevier B.V. All rights reserved.
Similar articles
-
Interleukin 7 receptor polymorphisms and the risk of multiple sclerosis: A meta-analysis.Mult Scler Relat Disord. 2016 Jul;8:66-73. doi: 10.1016/j.msard.2016.05.001. Epub 2016 May 2. Mult Scler Relat Disord. 2016. PMID: 27456877 Review.
-
The T244I variant of the interleukin-7 receptor-alpha gene and multiple sclerosis.Tissue Antigens. 2008 Aug;72(2):158-61. doi: 10.1111/j.1399-0039.2008.01075.x. Tissue Antigens. 2008. PMID: 18721276
-
Association between the IL7R T244I polymorphism and multiple sclerosis risk: a meta analysis.Neurol Sci. 2016 Sep;37(9):1467-74. doi: 10.1007/s10072-016-2608-8. Epub 2016 May 17. Neurol Sci. 2016. PMID: 27188999
-
Matrix metalloproteinases (MMPs) family gene polymorphisms and the risk of multiple sclerosis: systematic review and meta-analysis.BMC Neurol. 2020 May 29;20(1):218. doi: 10.1186/s12883-020-01804-2. BMC Neurol. 2020. PMID: 32471473 Free PMC article.
-
Interleukin 7 receptor T244I polymorphism and the multiple sclerosis susceptibility: a meta-analysis.J Neuroimmunol. 2020 Apr 15;341:577166. doi: 10.1016/j.jneuroim.2020.577166. Epub 2020 Jan 22. J Neuroimmunol. 2020. PMID: 32062178 Review.
Cited by
-
New Insights into Risk Genes and Their Candidates in Multiple Sclerosis.Neurol Int. 2022 Dec 29;15(1):24-39. doi: 10.3390/neurolint15010003. Neurol Int. 2022. PMID: 36648967 Free PMC article. Review.
-
Analysis of herpesvirus infection and genome single nucleotide polymorphism risk factors in multiple sclerosis, Volga federal district, Russia.Front Immunol. 2022 Nov 14;13:1010605. doi: 10.3389/fimmu.2022.1010605. eCollection 2022. Front Immunol. 2022. PMID: 36451826 Free PMC article.
-
Hypoxia in multiple sclerosis.Redox Biol. 2025 Jun;83:103666. doi: 10.1016/j.redox.2025.103666. Epub 2025 May 6. Redox Biol. 2025. PMID: 40347693 Free PMC article. Review.
-
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma.Cancer Biol Med. 2023 Jun 27;20(8):599-626. doi: 10.20892/j.issn.2095-3941.2023.0039. Cancer Biol Med. 2023. PMID: 37381714 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical